S
Sattanathan Paramasivan
Researcher at Wesleyan University
Publications - 8
Citations - 568
Sattanathan Paramasivan is an academic researcher from Wesleyan University. The author has contributed to research in topics: Prodrug & Telmisartan. The author has an hindex of 3, co-authored 6 publications receiving 515 citations.
Papers
More filters
Journal ArticleDOI
Circular dichroism of quadruplex DNAs: applications to structure, cation effects and ligand binding.
TL;DR: In this article four case studies are presented to indicate the strengths and limitations of CD in investigations of the properties of quadruplex structures formed by telomere repeat sequences.
Journal ArticleDOI
Mix and measure fluorescence screening for selective quadruplex binders
TL;DR: A mix and measure fluorescent screening method has been developed, that utilizes multiple reporter molecules that bind to different features of quadruplex DNA that have the potential to form quadruplex structures.
Journal ArticleDOI
Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs.
Matthew R. Golder,Jenny Liu,Jannik N. Andersen,Michail Shipitsin,Farrukh Vohidov,Hung V.-T. Nguyen,Deborah C. Ehrlich,Sung Jin Huh,Bhavatarini Vangamudi,Kyriakos D. Economides,Allison M. Neenan,James C. Ackley,Joelle Baddour,Sattanathan Paramasivan,Samantha W. Brady,Eric J. Held,Lawrence A. Reiter,Jennifer K. Saucier-Sawyer,Paul W. Kopesky,Donald E. Chickering,Peter Blume-Jensen,Jeremiah A. Johnson +21 more
TL;DR: In this article, the authors optimized the release of active telmisartan in fibrotic liver to be depot-like (that is, a constant therapeutic concentration) through the molecular design of brush-arm star polymers, and showed that these lead to improved efficacy and to the avoidance of dose-limiting hypotension in both metabolically and chemically induced mouse models of hepatic fibrosis.
Journal ArticleDOI
Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities
Farrukh Vohidov,Jannik N. Andersen,Kyriakos D. Economides,Michail Shipitsin,Olga Burenkova,James C. Ackley,Bhavatarini Vangamudi,Hung V.-T. Nguyen,Nolan M. Gallagher,Peyton Shieh,Matthew R. Golder,Jenny Liu,William K. Dahlberg,Deborah J. C. Ehrlich,Julie Kim,Samantha L. Kristufek,Sung Jin Huh,Allison M. Neenan,Joelle Baddour,Sattanathan Paramasivan,Elisa de Stanchina,Gaurab Kc,David J. Turnquist,Jennifer K. Saucier-Sawyer,Paul W. Kopesky,Samantha W. Brady,Michael J. Jessel,Lawrence A. Reiter,Donald E. Chickering,Jeremiah A. Johnson,Peter Blume-Jensen +30 more
TL;DR: In this article, a macromolecular prodrug platform for predictive prodrug design was proposed, using bromodomain and extra-terminal (BET) protein inhibitors.
Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs
Matthew R. Golder,Jenny Liu,Jannik N. Andersen,Michail Shipitsin,Farrukh Vohidov,Hung V.-T. Nguyen,Deborah C. Ehrlich,Sung Jin Huh,Bhavatarini Vangamudi,Kyriakos D. Economides,Allison M. Neenan,James C. Ackley,Joelle Baddour,Sattanathan Paramasivan,Samantha W. Brady,Eric J. Held,Lawrence A. Reiter,Jennifer K. Saucier-Sawyer,Paul W. Kopesky,Donald E. Chickering,Peter Blume-Jensen,Jeremiah A. Johnson +21 more
TL;DR: Macromolecular telmisartan prodrugs optimized for preferential release in fibrotic liver tissue reduce liver fibrosis in mouse models, and are retained and well tolerated in the liver tissue of rats and dogs.